Promoter holding
64.27%
BP
Bandaram Pharma Packtech Limited - Due diligence report
A 360° intelligence report on Bandaram Pharma Packtech Limited: trust score, financial health, credit view, compliance, directors, growth an…
Full Due-Diligence Report + Documents
- Unlock all financial figures & 5-year trends
- Full trust, health & credit-risk scores
- Director details, charges & MCA documents
₹700
₹449
Save ₹251
excl. GST
Or from ₹279/report with credits
View credit packages
Company Credits – Starter
- One credit unlocks this full due-diligence report
- Use across any company’s report, anytime
- Credits valid for 12 months
Choose your own credit amount
View credit packages
Bandaram Pharma Packtech Limited — 360° Intelligence Report
Generated from MCA filings & public records69/100
Trust Score
Moderate
Bandaram Pharma Packtech Limited is assessed as Moderate with a Trust Score of 69/100. Bandaram Pharma Packtech Limited is an active public limited indian non-government company incorporated in 1993, operating in the Manufacturing sector. The company has shown revenue growth across its recent filed years. It was profitable in its latest filed year. Based on MCA filings and public records, it currently shows a high compliance risk and low financial risk profile.
Report generated on 04 Oct 2026 from the latest processed filings. Bandaram Pharma Packtech Limited snapshot & full profile →
Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.
02
Score Card
Higher is safer · rule-based & explainableTrust ScoreModerate
69/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreCaution Indicated
34/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreLow Risk
80/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreModerate
55/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
85/100
Board strength, DIN status, churn and network.
Growth ScoreLow Risk
90/100
Revenue, profit, asset and hiring momentum.
Distress ScoreLow Risk
80/100
Early-warning signals - higher means fewer warnings.
03
Financial Intelligence Dashboard
Standalone · 4 filed year(s)Unlock the full 5-year financial dashboard with charts and year-wise figures.
Get full accessScores and observations on this page are already computed from the real filings - only the underlying figures are locked.
04
Credit & Compliance Intelligence
Why the scores are what they are
Credit Risk Score: 55/100 Moderate
- Liabilities ≈ 38% EBITDA - stretched.
- Working-capital cover adequate.
- Profitable - internal accruals available.
Charges position: 2 open (50.00 Lakh) · 3 satisfied (18.42 cr).
Banking relationships (from registered charges)
| Lender | Charges | Amount |
|---|---|---|
| Others | 1 | 48.0 cr |
| State Bank Of India; | 3 | 48.0 cr |
| Union Bank Of India | 1 | 48.0 cr |
Compliance Score: 34/100 Caution Indicated
- Company status is Active as per MCA.
- Balance sheet slightly behind (Mar 2025).
- Flagged by authority: DSE, BSE, NCLT.
- Litigation present in 2 court forum(s).
- 2 auditor resignation(s) filed - latest: Srinivas P & Associates on 2019-06-01.
- 1 active GST registration(s).
Legal cases on record (2)
05
Director Intelligence
Stability score: 85/100| Name | DIN / PAN | Designation | Appointed | Tenure | DIN status |
|---|---|---|---|---|---|
| SUMAN MALLU | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| BHANDARAM PREMSAI REDDY | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| SURYAPRAKASA RAO BOMMISETTI | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| Neha Kankariya | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| BHANDARAM SATHYAVATHI | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| DEEPAK REDDY BANDARAM | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| SIVA KUMAR VELLANKI | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| SIVA KUMAR VELLANKI | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| BHANDARAM MUNIRATNAM REDDY | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| Kankariya Neha | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| Mounika Pammi | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| Eswar Reddy Putturu | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
- 12 directors on the board.
- No disqualified or deactivated DINs.
- 3 director exit(s) in the last 3 years.
Director & KMP remuneration (FY 2022)
| Name | Designation | Total remuneration |
|---|---|---|
| A K Sharma | Managing Director | 2.4 cr |
| R Mehta | Whole-time Director | 1.6 cr |
| S Iyer | CFO | 95.0 L |
Remuneration is disclosed in the latest annual return. Unlock full report
06
Ownership & Group Intelligence
As per FY 2022 annual returnPublic / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
2 allotment(s) · 0 transfer(s)
Promoters hold a dominant controlling stake - exact percentages are part of the full report.
Key managerial personnel: DEEPAK REDDY BANDARAM (Managing Director) · SIVA KUMAR VELLANKI (CFO) · SIVA KUMAR VELLANKI (CFO)
Full shareholding pattern, group structure & capital events →
07
Risk Intelligence Center
Growth 90 · Distress 80
Growth signals & trust indicators
Revenue acceleration: +1.42 over 3 year(s).
Profit expanded 2.1x year-on-year.
Asset base grew 24% - capacity expansion.
Net margin improved to 0.86.
Operating for 33+ years.
Active GST registration(s).
Distress signals & risk flags
Outside liabilities up 61% in a year.
Compliance score is weak (34/100).
2 open charge(s) registered - assets are encumbered.
2 auditor resignation(s) on record - review the stated reasons.
2 court case(s) on record - see the legal section for details.
08
Stakeholder Verdicts
Vendor · Banker · InvestorVendor due diligence58/100
Review suggested
Suitability as a supplier / customer counterparty.
- Check the compliance flags before onboarding.
- 1 distress signal(s) - see Risk Center.
- Financial filings available for verification.
Banker assessment57/100
Mixed indicators - deeper appraisal suggested
Indicative lending comfort for banks, NBFCs and trade credit.
- Debt capacity assessed from filed statements.
- 2 open charge(s) of 50.00 Lakh already registered.
- Compliance gaps should be priced into terms.
Investor view81/100
Positive growth indicators
Growth quality and scalability through an investor lens.
- 4 growth signal(s) detected.
- Margin and return trends computable from filings.
- Management team looks stable.
09
MCA Filings & Events Timeline
Latest 15 events30 Jan 2026
Director appointed
Eswar Reddy Putturu (Director)
23 Dec 2025
Charge satisfied
Others
29 Sep 2025
Last AGM held
Annual general meeting
20 Jun 2025
Director appointed
Mounika Pammi (Director)
30 May 2025
Director ceased
VENKATA SUBRAMANYA RAJARAM CHITTULURU
31 Mar 2025
Latest balance sheet
Filed with ROC
14 Feb 2025
Director ceased
NADELLA SRINIVASULA KALKI AAKARSH RAJ
18 Jan 2024
Charge created
Others - 10.00 cr
11 Jan 2024
Director ceased
Priyanka Agarwal
06 Oct 2023
Director appointed
Kankariya Neha (Company Secretary)
01 Sep 2023
Director appointed
SUMAN MALLU (Additional Director)
Director appointed
Neha Kankariya (Company Secretary)
31 Aug 2023
Director ceased
HARISH SHARMA
15 Mar 2023
Director ceased
AAKANKSHA
07 Feb 2023
Director appointed
DEEPAK REDDY BANDARAM (Managing Director)
10
Key Observations
Auto-generated from the data aboveRevenue grew 38% over the last 3 financial year(s).
Debt-to-equity stands at 1.42 - leverage worth monitoring.
Net worth is positive.
12 active director(s) / partner(s); board looks stable and experienced.
1 active GST registration(s) indicate ongoing business operations.
Promoters hold a dominant controlling stake as per the FY 2022 annual return.
Director / KMP remuneration is disclosed in the latest annual return - exact figures available in the full report.
Capital has been raised through 2 security allotment(s) - amounts available in the full report.
| Company | CIN | Location |
|---|---|---|
| Seagate Speciality Products Private Limited | U74120MH2011PTC223885 | Mumbai, Maharashtra, India |
| Pgl Tube Private Limited | U25209DL2019PTC357647 | Delhi, Delhi, India |
| Stickwell Bonding Private Limited | U21099GJ2021PTC120307 | Kamrej, Gujarat, India |
| Swaharsh Paper Mills Private Limited | U21093PN2018PTC176011 | Pune, Maharashtra, India |
| Mahavir Global Vantage Private Limited | U21010MH1996PTC100420 | Mumbai, Maharashtra, India |
| Micro Med Charts Manufacturing Company Private Limited | U51909TN2005PTC057246 | Chennai, Tamil Nadu, India |
| Ghaziabad Technocrate Consultants Private Limited | U74899DL1994PTC062261 | East Delhi, Delhi, India |
| North West Paperkraft Private Limited | U21029HR2003PTC035112 | Karnal, Haryana, India |
12
Who Uses This Report
CA · CS · Banker · Investor · VendorChartered Accountants (CA)
Verify Bandaram Pharma Packtech Limited before audits and certifications: compliance score 34/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.
Company Secretaries (CS)
Track statutory health of Bandaram Pharma Packtech Limited: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.
Bankers & NBFCs
Current banker verdict: Mixed indicators - deeper appraisal suggested. Credit risk score 55/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.
Investors & Analysts
Investor view: Positive growth indicators. Growth score 90/100, margin trends, ownership structure and peer set for Bandaram Pharma Packtech Limited - screening before a deeper diligence.
Vendors & Procurement Teams
Vendor verdict: Review suggested. Trust score 69/100, distress signals and MSME payment-delay disclosures - know whether Bandaram Pharma Packtech Limited pays its suppliers before you extend credit terms.
Lawyers & Compliance Teams
Litigation footprint (2 case(s) on record), regulatory flags, charge documents trail and director networks for Bandaram Pharma Packtech Limited - groundwork for KYC, onboarding and disputes.
13
Frequently Asked Questions
Is Bandaram Pharma Packtech Limited an active company?
Bandaram Pharma Packtech Limited has MCA status “Active” with a compliance score of 34/100 (Caution Indicated).
Is Bandaram Pharma Packtech Limited financially healthy?
Bandaram Pharma Packtech Limited has a Financial Health Score of 80/100 (Low Risk) based on its filed financial statements.
Should I do business with Bandaram Pharma Packtech Limited?
Its overall Trust Score is 69/100 (Moderate). Vendor verdict: Review suggested. Review the risk flags in the Risk Intelligence Center before deciding.
Who controls Bandaram Pharma Packtech Limited?
Promoters hold a dominant controlling stake - exact percentages are in the full report. 12 active director(s) are on record.
Does Bandaram Pharma Packtech Limited have loans or charges against its assets?
2 open charge(s) are registered against its assets, and 3 earlier charge(s) stand satisfied.
Is Bandaram Pharma Packtech Limited up to date with its ROC filings?
Balance sheet slightly behind (Mar 2025). Overall compliance score: 34/100 (Caution Indicated).
Is it risky to lend to Bandaram Pharma Packtech Limited?
Its Credit Risk Score is 55/100 (Moderate). Banker verdict: Mixed indicators - deeper appraisal suggested.
Disclaimer: This report is generated automatically from MCA filings and public records as available
in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the
underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are
not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice.
Verify from official sources and consult a qualified professional before any business, lending or investment decision.
If you represent this company and believe any information is inaccurate or outdated,
report it here and we will review promptly.
